| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |